MDxHealth S.A.
MDXH
Rang în acțiuni
#21613
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Preț acțiune
$3.39
Ultima sincronizare: 2023-12-15
Capitalizare de piață
$96.16M
Schimbare (1 zi)
-1.73%
Schimbare (1 an)
0.01%
Țară
BE
Tranzacționează MDxHealth S.A. (MDXH)
Categorie
Healthcare
Istoric al prețului acțiunii pentru MDxHealth S.A. (MDXH)
Cel mai mare preț de închidere: $3.30 pe 2023-12-01
Cel mai mic preț de închidere: $109.85 pe 2008-08-01
Cel mai mic preț de închidere: $109.85 pe 2008-08-01
Istoric al prețului acțiunii pentru MDxHealth S.A. din 2008 până în 2026
Evoluția anuală a prețului acțiunii
| An | Performanță |
|---|---|
| 2023 | -52.10% |
| 2022 | -33.51% |
| 2021 | 0.16% |
| 2020 | -8.63% |
| 2019 | -47.39% |
| 2018 | -49.31% |
| 2017 | -10.95% |
| 2016 | 3.69% |
| 2015 | -5.94% |
| 2014 | 20.96% |
| 2013 | 75.72% |
| 2012 | 7.83% |
| 2011 | -80.58% |
| 2008 | 0.00% |
Prețul acțiunii pentru companii similare sau concurente
| Companie | Preț acțiune | Variație 1an% | Țara |
|---|---|---|---|
| $676.74 | 19.31% |
US
|
|
| $230.01 | 5.46% |
US
|
|
| $396.28 | 110.76% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $173.08 | 18.65% |
US
|
